Virtual colonoscopy tops conventional screening

Article

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

The removal of lesions 6 mm or greater found by CT colonography screening is more cost-effective, safer, and just as clinically effective as colonoscopy or flexible sigmoidoscopy, according to a study in the June 1 issue of Cancer.

Dr. Perry Pickhardt, an associate professor of radiology at the University of Wisconsin, and Dr. Cesare Hassan, a gastroenterologist in Rome, collaborated on the analysis. Their findings contradict previous ones showing that colonoscopy and flexible sigmoidoscopy of all sizes of polyps are more cost-effective than CT colonography. Earlier studies, however, ignored CT colonography guidelines on reporting only polyps greater than 5 mm. The cost per life-year gained from CT screening with a 6-mm threshold for follow-up was $4361 compared with $9180 for colonoscopy. The cost per life-year gained with CT screening with no polyp size threshold was $7138, compared with $7407 for flexible sigmoidoscopy.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.